Bone density: A surrogate for estrogen exposure or a systemic inflammatory disorder?

Menopause

Volumn 19, Issue 6, 2012, Pages 606-607

  Birge, Stanley J ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ALZHEIMER DISEASE; BONE DENSITY; BONE METABOLISM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COGNITIVE DEFECT; CORONARY ARTERY DISEASE; DEPRESSION; EDITORIAL; HORMONAL THERAPY; HUMAN; MUSCLE ATROPHY; MUSCLE MASS; MUSCLE STRENGTH; MUSCLE WEAKNESS; OSTEOPOROSIS; OVARIECTOMY; POSTMENOPAUSE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

BONE DENSITY; FEMALE; HUMANS; MILD COGNITIVE IMPAIRMENT; POSTMENOPAUSE;

EID: 84862121214     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e318254449f     Document Type: Editorial

References (16)

1. Lee D-Y, Na DL, Seo SW, et al. Association between cognitive impairment and bone mineral density in postmenopausal women. Menopause 2012;19:636-641.
2. Lui LY, Stone K, Cauley JA, et al. Bone loss predicts subsequent cognitive decline in older women: the Study of Osteoporotic Fractures. J Am Geriatr Soc 2003;51:38-43.
3. Zandi PP, Carlson MC, Plassman BL, et al. Hormone replacement therapy and incidence of Alzheimer's disease in older women: the Cache County Study. JAMA 2002;288:2123-2129.
4. Naessen T, Lindmark B, Larsen HC. Hormone therapy and postural balance in elderly women. Menopause 2007:14:1020-1024.
5. Shufelt CL, Johson BD, Berga SL, et al. Timing of hormone therapy, type of menopause, and coronary disease in women: data from the National Heart, Lung, and Blood InstituteYsponsored Women's Ischemia Syndrome Evaluation. Menopause 2011;18:943-950.
6. Rocca WA, Bower JH, Maraganore DM, et al. Increased risk of cognitive impairment of dementia in women who underwent oophorectomy before menopause. Neurology 2007;69:1074-1083.
7. Rocca WA, Bower JH, Maraganore DM, et al. Increased risk of parkinsonism in women who underwent oophorectomy before menopause. Neurology 2008:70:200-209.
8. Pinkerton JV, Henderson VW. Estrogen and cognition, with a focus on Alzheimer's disease. Semin Reprod Med. 2005;23:172-179.
9. Salari P, Abdollahi M. A comprehensive review of the shared roles of inflammatory cytokines in osteoporosis and cardiovascular diseases as two common old people problem; actions toward development of new drugs. Int J Pharmacol 2011;7:552-567.
10. Von der Recke P, Hansen MA, Hassager C. The association between low bone mass at the menopause and cardiovascular mortality. Am J Med 1999;106:273-278.
11. Kuo H-K, Lipsitz LA. Cerebral white matter changes and geriatric syndromes: is there a link? J Gerontol Med Sci 2004;59A:818-826.
12. Birge SJ. Osteoporotic fractures: a brain or bone disease? Curr Osteoporos Rep 2008;6:57-61.
13. Liu-Ambrose T, Eng JJ, Khan KM, et al. Older women with osteoporosis have increased postural sway and weaker quadriceps strength than counterparts with normal bone mass: overlooked determinants of fracture risk? J Gerontol Med Sci 2003;58A:M862-M866.
14. Ginaldi L, Di Benedetto MC, De Marinis M. Osteoporosis, inflammation and ageing. Immun Aging 2005;2:14-18.
15. Munir J, Birge SJ. Vitamin D deficiency in pre-and post-menopausal women. Menopausal Manag 2008;17:10-21.
16. Stechschulte SA, Kirsner RS, Federman DG. Vitamin D: Bone and beyond, rationale and recommendations for supplementations. Am J Med 2009;122:793-802.